Fibrin Degradation Product Kit

Nanopia D-dimer

We created this page for medical staff.

  • *Read carefully the package insert before use.

Reference Data

Within-run reproducibility

(µg/mL)
  Sample 1 Sample 2
1 3.5 9.5
2 3.6 9.5
3 3.5 9.4
4 3.4 9.3
5 3.5 9.5
6 3.5 9.3
7 3.5 9.4
8 3.6 9.5
9 3.5 9.5
10 3.5 9.3
Mean 3.5 9.4
S.D. 0.06 0.09
C.V. (%) 1.6 1.0
Max. 3.6 9.5
Min. 3.4 9.3
Range 0.2 0.2

On-Board Stability

[on Coapresta 2000]

On-Board Stability

Interference

  Concentration Measured Value(µg/mL)
Base Plasma Spiked Plasma
Unconjugated Bilirubin 20 mg/dL 2.70 2.80
Conjugated Bilirubin 20 mg/dL 2.80 2.80
Hemoglobin 500 mg/dL 2.12 2.14
Chyle 2500 FTU 2.17 2.04

Linearity

Linearity

Assay Procedure

Assay Procedure

"Nanopia" is a trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
"Coapresta" and all related logos are trademarks or registered trademarks of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.

We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.